Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.
about
Efficacy and patient tolerability of travoprost BAK-free solution in patients with open-angle glaucoma and ocular hypertension.Incidence, severity and factors related to drug-induced keratoepitheliopathy with glaucoma medications.Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Incidence of new coding for dry eye and ocular infection in open-angle glaucoma and ocular hypertension patients treated with prostaglandin analogs: retrospective analysis of three medical/pharmacy claims databases.Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial.Short-term effect of topical antiglaucoma medication on tear-film stability, tear secretion, and corneal sensitivity in healthy subjects.Challenges in the clinical measurement of ocular surface disease in glaucoma patients.Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.Comparison of a non-preserved 0.1% T-Gel eye gel (single dose unit) with a preserved 0.1% T-Gel eye gel (multidose) in ocular hypertension and glaucomatous patients.Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery?Comparing the effectiveness of selective laser trabeculoplasty with topical medication as initial treatment (the Glaucoma Initial Treatment Study): study protocol for a randomised controlled trial.Clinical analysis of tear film after lamellar keratoplasty.Comparison of Cytotoxic Effects on Rabbit Corneal Endothelium between Preservative-free and Preservative-containing Dorzolamide/timololControversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.Antiglaucoma drugs: The role of preservative-free formulations.Comparison of the ocular tolerability of a latanoprost cationic emulsion versus conventional formulations of prostaglandins: an in vivo toxicity assayOcular preservatives: associated risks and newer options.Current and emerging medical therapies in the treatment of glaucoma.Ophthalmic preservatives: focus on polyquaternium-1.Tafluprost for glaucoma.Comparative cross-sectional analysis of the effects of topical antiglaucoma drugs on the ocular surface.Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery.N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations.A novel eye drop of alpha tocopherol to prevent ocular oxidant damage: improve the stability and ocular efficacy.Analysis of the effects of preservative-free tafluprost on the tear proteome.Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.Ocular Surface Changes in Primary Open Angle Glaucoma with Long Term Topical Anti Glaucoma Medication.Effects of prostaglandin analog therapy on the ocular surface of glaucoma patients.Barriers to Glaucoma Medication Compliance Among Veterans: Dry Eye Symptoms and Anxiety Disorders.Switching from concomitant latanoprost 0.005% and timolol 0.5% to a fixed combination of travoprost 0.004%/timolol 0.5% in patients with primary open-angle glaucoma and ocular hypertension: a 6-month, multicenter, cohort study.Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.Multidose Preservative Free Eyedrops by Selective Removal of Benzalkonium Chloride from Ocular Formulations.Association between meibomian gland dysfunction and compliance of topical prostaglandin analogs in patients with normal tension glaucoma.Efficacy and ocular surface tolerability of preservative-free tafluprost 0.0015%: a 6-month, single-blind, observational study on naïve ocular hypertension or glaucoma patients.Iatrogenic glaucoma therapy failure: the adverse effects of topical antiglaucoma medication treatment outcome.
P2860
Q30435051-45B67E26-24ED-4EA4-832E-5AD61386E87FQ33819802-C564C7C4-5FCF-4237-B388-47283A379CFBQ33857744-CDAFF11C-954A-43F6-AE24-E10816579465Q33932282-5755ED91-60B2-40C2-AFDE-D8C82783E126Q34226897-C6FA57F8-FFF6-4C55-96B5-AA85DE4DAF88Q34956734-7E5036FA-48C1-4D58-9ADB-27DDDF6C6830Q35555771-6E296F14-F355-4A11-A08C-A03C73032E31Q35589561-23380D5F-EDF7-42C1-A1CA-0F6F0005ED68Q35761832-87775CD4-FDA7-41DA-B5DE-606B16636A9DQ35762703-0424FC73-1508-49D7-814B-4FE685E2C606Q35771380-AAE8F938-08D5-455E-A2D0-BA100EF34251Q35924244-CC52B602-8808-4B5C-B1FC-7F3F03DD9CD4Q36127299-5D7F3D84-2EB2-45E2-8A62-E70C739D9BC2Q36543265-2407B14A-02E1-44E9-8616-4ADA69C548A8Q36898923-FB1B7B3F-F18B-43C5-B4D8-F5D9122739E7Q36908446-0BF32180-FCB8-4239-BC1C-44E46996F2D2Q37060734-2CF9BD37-03F9-4B3B-87B3-60CCB8530226Q37318278-095E3D67-0C92-4B12-9F73-AE7D33936F1DQ37510923-B3036EA1-2ACF-4E02-8188-74B4A22A1B8CQ37853195-C91BBD3D-E5F3-449B-AC27-21F7BE73B997Q37929746-E26E6B3D-064B-4277-AF46-5452C25AA50CQ37931967-A11EC2B6-FC57-4179-BECC-E90F27B84D82Q38096951-712FC64C-776F-4C49-B6D1-8E70ED2A55C7Q38133883-32C5F6C3-4657-4687-85B2-7EE7EF7863FEQ38698730-F33C579E-5F1C-4540-A11A-B3D659A205F2Q38884492-880230EC-376D-44C2-B20E-58006310BB7BQ39177865-7CB521EF-CC66-4887-A7A8-AC36DD9352FDQ40573088-5E418EE6-F32F-49F5-96B2-F564B2710EF8Q41668980-DCA37F30-A932-4333-8BA0-F5EEE97E6EC7Q41703661-844F908C-B16F-49F4-94D0-EF32E55DC74BQ41717624-FE5F91C3-0924-42D6-B8EC-F595118B939EQ42209156-D18DDE40-7083-43CD-978F-244B53894B42Q43096347-A2E6F464-7C59-49D6-AE7D-28DA0F3A055CQ45326884-D97AAF03-005E-4077-B562-87A47B56ED37Q45929500-0CADEF54-0390-4764-A355-58EAD76F2772Q47381165-1E2564F9-2AE4-405A-AF9B-1A0CE6A68BF8Q47412971-66722576-FC05-4025-9C1A-9377BB555D32Q48133456-97D50A32-5A00-4B52-BCC5-FD75A6B86E36Q48429820-35057DF0-D82E-4A16-B3FF-3E35E3363AE0Q53520100-492A59B6-9BC6-4CF9-ACB9-172940210F5F
P2860
Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Short-term comparative study o ...... hloride in healthy volunteers.
@ast
Short-term comparative study o ...... hloride in healthy volunteers.
@en
type
label
Short-term comparative study o ...... hloride in healthy volunteers.
@ast
Short-term comparative study o ...... hloride in healthy volunteers.
@en
prefLabel
Short-term comparative study o ...... hloride in healthy volunteers.
@ast
Short-term comparative study o ...... hloride in healthy volunteers.
@en
P2860
P356
P1476
Short-term comparative study o ...... chloride in healthy volunteers
@en
P2093
C de Lunardo
P2860
P356
10.1136/BJO.82.1.39
P407
P577
1998-01-01T00:00:00Z